R. Pieters - Concepedia

Author

R. Pieters

Erasmus MC - Sophia Children’s Hospital

Also Known As

Pieters R, R Pieters, R. Pieters, R.C. Pieters, Rob Pieters, Robrecht Pieters

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Erasmus MC - Sophia Children’s Hospital Stichting Kinderoncologie Nederland Erasmus MC Vrije Universiteit Amsterdam Erasmus University Rotterdam

About

R. Pieters is an author at Erasmus MC - Sophia Children’s Hospital specializing in medicine, hematology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	15	1.3K
2	Cell Biology	5	5	246
3	Health Sciences	3	3	215
4	Public Health	1	1	151
5	Child Development	1	1	113

R. Pieters

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia–implications for treatment of infants R. Pieters, Monique L. den Boer, M. Durian, Leukemia Hematological MalignancyVitro Drug ResistancePediatric EpidemiologyPediatric HematologyImmunology	1998	242
The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia Pieter Van Vlierberghe, Martine van Grotel, H. Berna Beverloo, Blood	2006	165
TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia. N. L. Ramakers-Van Woerden, R. Pieters, A. H. Loonen, PubMed	2000	151
Incidence, Medical Resource Utilisation and Costs of Hyperuricemia and Tumour Lysis Syndrome in Patients with Acute Leukaemia and Non-Hodgkin's Lymphoma in Four European Countries L Annemans, K Moeremans, Mark Lamotte, Leukemia & lymphoma/Leukemia and lymphoma Renal PathologyPathologyTls CasesDialysis TherapyMedical Resource Utilisation	2002	151
Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol Vincent H. J. van der Velden, Lilia Corral, Maria Grazia Valsecchi, Leukemia Hematological MalignancyMixed-phenotype Acute LeukemiaHematologyPediatricsPathology	2009	150
Enhanced Levels of Soluble VCAM-1 in Sickle Cell Patients and Their Specific Increment during Vasoocclusive Crisis Ashley J. Duits, R. Pieters, A.W. Saleh, Clinical Immunology and Immunopathology Soluble Vcam-1PathogenesisHematologyImmunologyPathology	1996	124
The significance of PTEN and AKT aberrations in pediatric T-cell acute lymphoblastic leukemia Linda Zuurbier, Emanuel F. Petricoin, Maartje Vuerhard, Haematologica	2012	124
Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia Brian V. Balgobind, Iris H.I.M. Hollink, Susan T.C.J.M. Arentsen-Peters, Haematologica	2011	118
Evaluation of gene expression signatures predictive of cytogenetic and molecular subtypes of pediatric acute myeloid leukemia Brian V. Balgobind, M. M. Van den Heuvel-Eibrink, R. X. De Menezes, Haematologica	2010	116
Long-term results of Dutch Childhood Oncology Group studies for children with acute lymphoblastic leukemia from 1984 to 2004 W. A. Kamps, K.M. van der Pal‐de Bruin, A. Veerman, Leukemia Long-term ResultsHematological MalignancyPediatric HematologyMedicineMixed-phenotype Acute Leukemia	2009	113

Page 1